Page last updated: 2024-09-04

atrasentan and Neoplasms

atrasentan has been researched along with Neoplasms in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (71.43)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aubert, JD; Juillerat-Jeanneret, L	1
Bazan, V; Bronte, G; Di Gaudio, F; Fanale, D; Gebbia, N; Rizzo, S; Russo, A	1
Bagnato, A; Battistini, B; Nelson, J; Nisen, P	1
Garber, K	1
André, AK; Carr, RA; Humerickhouse, R; Kindler, HL; Ratain, MJ; Ryan, CW; Undevia, SD; Vogelzang, NJ; Vokes, EE; Wang, Q	1
Choueiri, TK; Garcia, JA; Thakkar, SG	1
Lalich, M; Liu, G; McNeel, DG; Wilding, G	1

Reviews

4 review(s) available for atrasentan and Neoplasms

Article	Year
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis. Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18 Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrosis; Humans; Hypertension, Pulmonary; Neoplasms; Receptors, Endothelin	2016
Anti-endothelin drugs in solid tumors. Expert opinion on emerging drugs, 2010, Volume: 15, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Drug Delivery Systems; Drugs, Investigational; Endothelin Receptor Antagonists; Endothelins; Humans; Male; Models, Biological; Neoplasms; Prostatic Neoplasms; Pyrrolidines; Receptors, Endothelin; Signal Transduction	2010
The endothelin axis: emerging role in cancer. Nature reviews. Cancer, 2003, Volume: 3, Issue:2 Topics: Amino Acid Sequence; Antineoplastic Agents; Atrasentan; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Humans; Male; Neoplasms; Prostatic Neoplasms; Protein Conformation; Pyrrolidines; Receptor, Endothelin A; Receptors, Endothelin	2003
Endothelin receptor antagonists in cancer therapy. Cancer investigation, 2007, Volume: 25, Issue:8 Topics: Atrasentan; Bosentan; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Male; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Pyrimidines; Pyrrolidines; Receptors, Endothelin; Signal Transduction; Sulfonamides	2007

Trials

1 trial(s) available for atrasentan and Neoplasms

Article	Year
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-01, Volume: 10, Issue:13 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Atrasentan; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Pyrrolidines; Receptors, Endothelin; Sex Factors; Time Factors	2004

Article

Year

Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-01, Volume: 10, Issue:13

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Atrasentan; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Pyrrolidines; Receptors, Endothelin; Sex Factors; Time Factors

2004

Other Studies

2 other study(ies) available for atrasentan and Neoplasms

Article	Year
Why it hurts: researchers seek mechanisms of cancer pain. Journal of the National Cancer Institute, 2003, Jun-04, Volume: 95, Issue:11 Topics: Acidosis; Analgesics; Animals; Antineoplastic Agents; Atrasentan; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Glycoproteins; Humans; Ion Channels; Neoplasms; Osteoprotegerin; Pain; Pyrrolidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor	2003
Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics. Current oncology reports, 2006, Volume: 8, Issue:2 Topics: Antineoplastic Agents; Atrasentan; Clinical Trials as Topic; Disease Progression; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Male; Neoplasms; Prostatic Neoplasms; Pyrrolidines; Receptor, Endothelin A; Receptors, Endothelin	2006

Article

Year

Why it hurts: researchers seek mechanisms of cancer pain.

Journal of the National Cancer Institute, 2003, Jun-04, Volume: 95, Issue:11

Topics: Acidosis; Analgesics; Animals; Antineoplastic Agents; Atrasentan; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Glycoproteins; Humans; Ion Channels; Neoplasms; Osteoprotegerin; Pain; Pyrrolidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor

2003

Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics.

Current oncology reports, 2006, Volume: 8, Issue:2

Topics: Antineoplastic Agents; Atrasentan; Clinical Trials as Topic; Disease Progression; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Male; Neoplasms; Prostatic Neoplasms; Pyrrolidines; Receptor, Endothelin A; Receptors, Endothelin

2006